Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Tom_Polen
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:division |
gptkb:BD_Interventional
gptkb:BD_Life_Sciences gptkb:BD_Medical |
| gptkbp:foundedYear |
1897
|
| gptkbp:founder |
gptkb:Fairleigh_S._Dickinson
gptkb:Maxwell_Becton |
| gptkbp:fullName |
gptkb:Becton,_Dickinson_and_Company
|
| gptkbp:headquartersLocation |
gptkb:Franklin_Lakes,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
BDX
|
| gptkbp:industry |
medical device
|
| gptkbp:ISIN |
US0758871091
|
| gptkbp:listedOn |
gptkb:NYSE
|
| gptkbp:marketCap |
~$70 billion (2023)
|
| gptkbp:netIncome |
~$1.1 billion (2023)
|
| gptkbp:numberOfEmployees |
~77,000
|
| gptkbp:products |
gptkb:research_institute
medical devices diagnostics |
| gptkbp:revenue |
~$18.87 billion (2023)
|
| gptkbp:SIC |
3841
|
| gptkbp:stockSymbol |
gptkb:BDX
|
| gptkbp:subsidiary |
gptkb:BD_Biosciences
gptkb:C._R._Bard gptkb:CareFusion |
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.bd.com
|
| gptkbp:bfsParent |
gptkb:BD
|
| gptkbp:bfsLayer |
5
|